CERo Therapeutics Holdings, Inc. CERO
$0.01
$0.004.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | 105.40K | 500.00K | -- |
| Gross Profit | -- | -- | -105.40K | -500.00K | -- |
| SG&A Expenses | 2.11M | 2.51M | 3.80M | 1.98M | 2.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.85M | 4.85M | 4.53M | 4.86M | 5.43M |
| Operating Income | -3.85M | -4.85M | -4.53M | -4.86M | -5.43M |
| Income Before Tax | -1.03M | -5.89M | -4.54M | -4.86M | -5.42M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.03M | -5.89M | -4.54M | -4.86M | -5.42M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.03M | -5.89M | -4.54M | -4.86M | -5.42M |
| EBIT | -3.85M | -4.85M | -4.53M | -4.86M | -5.43M |
| EBITDA | -3.79M | -4.78M | -4.46M | -4.79M | -5.36M |
| EPS Basic | -0.70 | -0.20 | -3.23 | -9.10 | -61.71 |
| Normalized Basic EPS | -0.11 | -0.13 | -0.19 | -2.40 | -6.94 |
| EPS Diluted | -0.70 | -0.20 | -3.23 | -9.10 | -61.71 |
| Normalized Diluted EPS | -0.11 | -0.13 | -0.19 | -2.40 | -6.94 |
| Average Basic Shares Outstanding | 42.18M | 28.76M | 14.98M | 1.26M | 488.10K |
| Average Diluted Shares Outstanding | 42.18M | 28.76M | 14.98M | 1.26M | 488.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |